Lack of Assurance of Sterility: The product has the potential for solution to leak at the administrative port.
Take action
Contact the company
📍Recalling firmHospira Inc.375 N Field Dr · Lake Forest, IL 60045-2513
✎ GovInfoNow plain-language explainer
Hospira Inc. is recalling 30,840 bags of 0.9% Sodium Chloride Injection, USP (100mL VisIV Container) because the product may leak at the administrative port. This leakage creates a potential lack of sterility, which poses a risk to patients using the medication. The recall affects units distributed nationwide with NDC 0409-7984-11 and Lot # 42-306-C6. Read more at govinfonow.com/recall/45073-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-100ml.
“Hospira Recalls Sodium Chloride Injection Due to Sterility Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45073-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-100ml. Based on FDA recall #D-0334-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0334-2015%22&limit=1).
The FDA announced on 2014-12-22 that Hospira Inc. voluntarily recalled 30,840 bags of 0.9% Sodium Chloride Injection due to a lack of sterility assurance caused by potential leakage at the administrative port. This Class II recall was initiated by the firm and has been terminated.
The product has the potential for solution to leak at the administrative port, creating a lack of assurance of sterility. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls include the 2017-04-21 Hospira Infant Dextrose Injection recall for hair particulates, the 2016-11-01 Hospira Fentanyl Injection recall for broken ampule tips, and the 2016-08-15 Hospira DOBUTamine Injection recall for discoloration. Other recent recalls of similar products include Fresenius Kabi 1000mL Sodium Chloride Injection (2026-03-11), Fresenius Kabi 0.9% Sodium Chloride Injection (2026-03-11), and Fresenius Kabi 500mL Sodium Chloride Injection (2026-03-11).
How to tell if you have this one
Check if you have Hospira Inc. 0.9% Sodium Chloride Injection, USP, in a 100mL VisIV Container. Look for NDC 0409-7984-11 and Lot # 42-306-C6 on the packaging.
Brand
Hospira
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Recalled Bags
Do not use any bags matching NDC 0409-7984-11 and Lot # 42-306-C6 due to sterility risks.
Contact Healthcare Provider
If you received this product, speak with your doctor or nurse to determine if any medical monitoring is necessary.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 6 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0334-2015 (December 22, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0334-2015 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.